Koda Health, a Houston-based healthcare technology company focused on improving advance care planning and serious illness decision-making, has raised $7 million in an oversubscribed Series A funding round. The financing was led by Evidenced Ventures, with participation from Mudita Venture Partners, Techstars, and Texas Medical Center Venture Fund. The company plans to use the investment to expand its AI-enhanced patient decision support platform and scale its solutions across healthcare systems and payer organizations.

Founded in 2020, Koda Health develops technology designed to improve advance care planning, helping patients document their healthcare preferences and enabling providers to better understand patients’ goals during serious illness. The company’s platform combines artificial intelligence, patient engagement tools, and healthcare workflows to support conversations between patients, families, and care teams.

Evidenced Ventures led Koda Health’s $7 million Series A financing. The venture firm invests in healthcare technology companies focused on improving outcomes and reducing inefficiencies across the healthcare system. The investment supports Koda Health’s mission of addressing challenges associated with serious illness care, where patients and families often face complex medical decisions without sufficient preparation or support.

Mudita Venture Partners participated in the Series A round. The venture capital firm invests in healthcare and technology companies with the goal of supporting entrepreneurs developing solutions for major industry challenges. Mudita Venture Partners previously backed Koda Health and continued its support as the company entered a new stage of growth.

Techstars also participated in the financing. Koda Health previously joined the Techstars UnitedHealthcare Accelerator program, which supports startups developing healthcare innovations. Through the accelerator network, Koda Health gained access to mentorship, resources, and industry connections as it developed its technology platform.

Texas Medical Center Venture Fund participated as a strategic investor. The fund supports healthcare startups connected to the Texas Medical Center ecosystem and invests in companies developing technologies that can improve healthcare delivery. Koda Health’s relationship with the Texas Medical Center dates back to its early development stage, helping the company establish its presence in the Houston healthcare innovation community.

Koda Health’s platform focuses on advance care planning, an area of healthcare designed to help individuals communicate their treatment preferences before they face serious illness or situations where they may not be able to make decisions themselves. The company’s AI-enhanced tools are designed to help patients create personalized care plans while giving healthcare providers access to information that can guide treatment decisions.

The company’s technology addresses a significant challenge in healthcare: ensuring that medical care aligns with what patients value most. Koda Health has highlighted that many patients receive treatments that may not reflect their preferences because important conversations about goals of care often happen too late or do not occur at all. The company aims to make these conversations easier, earlier, and more scalable through digital tools.

Before its Series A financing, Koda Health raised earlier funding to develop its platform. In 2024, the company secured a Seed+ round led by Ecliptic Capital, with strategic investment from Memorial Hermann Health System, AARP, and the Texas Medical Center Venture Fund. That financing helped support the company’s continued development of digital advance care planning solutions.

Ecliptic Capital has supported companies working at the intersection of technology and healthcare innovation. Memorial Hermann Health System and the Texas Medical Center Venture Fund provided strategic healthcare industry support, reflecting interest from healthcare organizations in improving patient engagement and care coordination.

Koda Health’s funding comes as healthcare organizations increasingly explore artificial intelligence and digital tools to improve patient experiences and operational efficiency. Providers and payers are looking for solutions that can support better communication, reduce unnecessary interventions, and help align healthcare delivery with patient preferences.

The company has continued expanding partnerships with healthcare organizations and developing its platform for broader adoption. By combining AI technology with advance care planning expertise, Koda Health aims to help healthcare systems deliver more personalized and values-based care.

With the new investment from Evidenced Ventures, Mudita Venture Partners, Techstars, and the Texas Medical Center Venture Fund, Koda Health plans to accelerate growth, expand its technology capabilities, and bring AI-powered advance care planning tools to more patients and healthcare providers nationwide.

Related Articles